- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Canine PIVKA-Ⅱ antibody and antigen (recombinant protein)
Diagnostic anti-Canine PIVKA-Ⅱ antibodies pairs and antigen for animal health (animal Dog/Canine hepatocellular carcinoma) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-CAN-PIVKA-Ⅱ-Ag01 | Canine PIVKA-Ⅱ | $3090.00 |
| GMP-CAN-PIVKA-Ⅱ-Ab01 | Anti-Canine PIVKA-Ⅱ mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-PIVKA-Ⅱ-Ab02 | Anti-Canine PIVKA-Ⅱ mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-PIVKA-Ⅱ-Ab03 | Anti-Canine PIVKA-Ⅱ human monoclonal antibody (mAb) | $3090.00 |
| GMP-CAN-PIVKA-Ⅱ-Ab04 | Anti-Canine PIVKA-Ⅱ human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-CAN-PIVKA-Ⅱ-Ag01 |
| Product Name | Canine PIVKA-Ⅱ |
| Target/Biomarker | Canine PIVKA-Ⅱ |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Canine PIVKA-Ⅱ antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PIVKA-Ⅱ level test of animal Dog/Canine with hepatocellular carcinoma. |
| Tag | His | Reconized/Reactive Specics | Canine PIVKA-Ⅱ |
| Product description | Recombinant Canine PIVKA-Ⅱ protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-PIVKA-Ⅱ-Ab01,GMP-CAN-PIVKA-Ⅱ-Ab02 |
| Target/Biomarker | Canine PIVKA-Ⅱ |
| Product Name | Anti-Canine PIVKA-Ⅱ mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Canine PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine PIVKA-Ⅱ antibodies in Canine PIVKA-Ⅱ level test of animal Dog/Canine with hepatocellular carcinoma. |
| Product description | Anti-Canine PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine PIVKA-Ⅱ antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-CAN-PIVKA-Ⅱ-Ab03,GMP-CAN-PIVKA-Ⅱ-Ab04 |
| Target/Biomarker | Canine PIVKA-Ⅱ |
| Product Name | Anti-Canine PIVKA-Ⅱ human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Canine PIVKA-Ⅱ antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine PIVKA-Ⅱ antibodies in Canine PIVKA-Ⅱ level test of animal Dog/Canine with hepatocellular carcinoma. |
| Product description | Anti-Canine PIVKA-Ⅱ mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Canine PIVKA-Ⅱ, an intriguing biomarker, emerges as a critical element in the realm of canine health. Exclusive to dogs, this biomarker's significance lies in its role as an indicator of coagulation abnormalities and Vitamin K-dependent clotting factors. Canine PIVKA-Ⅱ serves as a marker that reflects the intricate interplay between hemostasis, liver function, and clotting factor synthesis.
The presence of Canine PIVKA-Ⅱ is closely associated with the activation of coagulation factors, especially those dependent on Vitamin K. In cases where Vitamin K metabolism is compromised, the levels of Canine PIVKA-Ⅱ may elevate, reflecting the body's efforts to sustain normal hemostasis despite impaired coagulation factors. Moreover, alterations in Canine PIVKA-Ⅱ levels can also indicate potential liver dysfunction, as the liver plays a central role in synthesizing clotting factors and Vitamin K.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
